C3.ai Inc vs Cassava Sciences Inc — how do they compare? C3.ai Inc trades at $10.6 (market cap $1.59B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: C3.ai Inc is far larger — about 33.3× Cassava Sciences Inc's market cap, and C3.ai Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| AI | FLNA | |
|---|---|---|
Market Cap | $1.59B | $47.75M |
Sector | Technology | Health |
52-Week High | $19.66 | $4.64 |
52-Week Low | $7.76 | $0.87 |
Enterprise Value | $1.02B | -$34.93M |
Trailing returns across standard periods
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →